When doing DCF modeling I usually go out 5 years. With a Vyvanse approval, we have a great future. With a Concerta and next gen (beyond CNS) positive BE trials we’re going to be blazing new trails. From what I have seen, healthcare companies in general over the past couple of years are being sold in PE world for crazy high multiples.
Market Data 
Markets 
AI
